Alaunos Therapeutics Form 4: Vieser Adds Shares, Receives $5 Options
Rhea-AI Filing Summary
Form 4 highlights: Director Jaime Vieser received new equity awards from Alaunos Therapeutics (TCRT) on 07/03/2025.
- Restricted Stock Units (RSUs): 3,400 common shares granted and fully vested immediately. This raised Vieser’s directly held stock from 17,759 to 21,159 shares.
- Employee Stock Options: 6,400 options with a $5.00 exercise price and 07/03/2035 expiry. One-twelfth vests each month; any unvested balance vests immediately before the 2026 annual meeting.
- Total beneficial ownership after the grant: 21,159 shares held directly, 2,100 shares held indirectly through children, and 13,503 shares held indirectly via Brushwood LLC where Vieser is Manager.
The awards were issued at $0.00 cost for the RSUs and standard option pricing for the options, indicating compensation rather than an open-market purchase. While the absolute numbers are modest relative to typical public-company share counts, the filing shows continued equity-based alignment between the director and shareholders.
Positive
- Director’s direct shareholding rises 19% (to 21,159 shares), improving insider alignment.
- 6,400 new options at $5 strike create performance-based incentive extending to 2035.
Negative
- None.
Insights
TL;DR: Compensation grant; small insider ownership increase, neutral market impact.
The transaction is a routine board compensation event. Vieser’s additional 3,400 RSUs and 6,400 options marginally increase insider ownership but do not involve cash purchases, so they offer limited signalling power. The $5 strike is likely above the recent trading price, providing incentive alignment without immediate dilution. Aggregate ownership (≈36.8 k shares/options) remains immaterial to Alaunos’s outstanding float, suggesting low fundamental impact on valuation or near-term supply-demand dynamics.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 6,400 | $0.00 | -- |
| Grant/Award | Common Stock | 3,400 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Represents a grant of restricted stock units (RSUs) which immediately vested upon grant. After the reported acquisition of the RSUs, the reporting person owned in aggregate 21,159 shares of common stock (17,759 previously owned shares, plus the instant grant of 3,400 RSUs). The shares are directly held by Brushwood LLC. The Reporting Person is the Manager of Brushwood LLC. One-twelfth of the Option vests each month on the monthly anniversary of July 3, 2025, with any amount that remains unvested on the date immediately preceding the Company's 2026 annual general meeting of stockholders vesting thereon.
AI-generated analysis. How Rhea-AI works. Not financial advice.
